Rosuvastatina e ciprofibrato no tratamento da dislipidemia em pacientes com HIV

Domingos, Hamilton; Cunha, Rivaldo Venâncio da; Paniago, Anamaria Mello Miranda; Souza, Albert Schiaveto de; Rodrigues, Renata London; Domingos, João Américo

doi:10.1590/s0066-782x2012005000096

Cited by 6 publications

(4 citation statements)

References 27 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Domingos et al [28] also stated that there was a predominance of patients on HAART therapy containing PI. Caramelli et al [29] pointed out that, after the introduction of HAART containing PI, a remarkable increase in triglycerides and total cholesterol and a slight decrease in HDL-C were observed.…”

Section: Discussionmentioning

confidence: 99%

The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS

et al. 2016

View full text Add to dashboard Cite

Cardiovascular events due to decompensated lipid metabolism are commonly found in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) patients using anti-retroviral therapy (HAART). Thus, the aim of this study was to identify the effect of a bioactive food compound (BFC) containing functional foods on individuals with HIV undergoing HAART. Particularly, this study aims to verify the clinical outcome in the change of the lipid profile due to the use of this compound. This study includes 115 individuals with HIV on HAART. All patients received dietary guidelines; however, sixty-one consumed BFC while fifty-one did not (NO BFC). Biochemical examinations and socio-demographic and clinical profiles were evaluated. As result, in patients using hypolipidemic and/or hypoglycemic drugs, there was 28.6% decrease in triglyceride levels (p < 0.001) in the NO BFC group, and 18.3% reduction in low density lipoprotein cholesterol (LDL-C) (p < 0.001) in the BFC group. In patients who did not use hypolipidemic and/or hypoglycemic drugs in the NO BFC group, there was 30.6% increase in triglycerides, 11.3% total cholesterol and 15.3% LDL-C levels (p < 0.001) while for the BFC group there was 4.5% reduction in total cholesterol (p < 0.001). In conclusion, this study evidenced that the dietary intervention containing BFC positively affected in lipid control, since these HIV/AIDS patients using HAART are more vulnerable to lipid disorders.

show abstract

“…Para o terceiro grupo, dos pacientes HIV positivos, Domingos et al 14 orientam o uso do ciprofibrato, da rosuvastatina ou da combinação de ambos, sendo efetivo, seguro e bem tolerado nos indivíduos com infecção pelo HIV.…”

Section: Resultsunclassified

Comparativo farmacológico de tratamento de dislipidemias em crianças, diabéticos, HIV-positivos e idosos

Reinaldo¹,

Cardoso²

2018

Arch Health Invest

View full text Add to dashboard Cite

Introdução: O estudo aqui apresentado fundamenta-se na associação de drogas para controle da dislipidemia em crianças, diabéticos, HIV-positivos e idosos. Objetivo: Discorrer acerca das dislipidemias sob o panorama dos fármacos de melhor escolha fazendo um paralelo entre os achados bibliográficos quanto a eficiência entre as principais drogas utilizadas no tratamento das dislipidemias. Material e Método: O presente estudo trata-se de levantamento bibliográfico sobre o tema através de achados de artigos científicos e demais materiais técnico-científicos. Resultados e Conclusão: Em crianças pode-se indicar a droga Ezetimibe como alternativa de vanguarda para o tratamento das mesmas, de forma que existem contraindicações neste grupo principalmente do ácido nicotínico ou fibratos, ficando ainda as estatinas como uma droga de primeira escolha. Para pacientes diabéticos contra indica-se o ácido nicotínico e sequestrantes de ácido biliar, visto que ambos alteram o índice glicêmico. Indica-se nestes casos os moduladores SRAA e as estatinas de intensidade moderada. Em Idosos verificou-se que as estatinas compreendem o tratamento de primeira escolha para reduzir os níveis de LDL (Lipoproteína de Baixa Densidade) e produzir pequenos aumentos de HDL (Lipoproteína de Alta Densidade) com declínio modesto em TG (Triglicérides), reduzindo a probabilidade de doenças cardiovasculares. Lembrando que é aceitável nos estudos selecionados a associação de um fibrato a uma estatina. E por fim os pacientes HIV – positivos, notou-se que o uso do ciprofibrato, da rosuvastatina ou da combinação de ambos, sendo efetivo, seguro, e bem tolerado por estes indivíduos.Descritores: Dislipidemias; Terapêutica; Complicações do Diabetes; Criança; Idoso; Soropositividade para HIV.

show abstract

“…Dyslipidaemia may worsen the situation of patients receiving HAART since it has been found to be associated with increased cardiovascular events (7,(33)(34)(35). It is reported that up to 81.5% of patients on HAART for at least 12 months develop dyslipidaemia (36).…”

Section: Discussionmentioning

confidence: 99%

Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced Dyslipidemia

Su¹,

Lu²,

Deng³

et al. 2015

West Indian Med J

View full text Add to dashboard Cite

show abstract

“…The latest data presented by the Joint United Nations Program on HIV (UNAIDS), in 2008, showed an increase in the number of people infected in Latin America and Brazil. 3 More recent data from the Brazilian Ministry of Health (2017) found that the number of people over 65 of age with HIV rose by 103% in the last 10 years.…”

Section: Changes In the Nutritional Status Of Elderly Patients With H...mentioning

confidence: 99%

Changes in the nutritional status of elderly patients with HIV diagnosis undergoing antiretroviral treatment

Miranda

Ignácio

Lopes

et al. 2022

BJHBS

View full text Add to dashboard Cite

Introduction: Acquired immunodeficiency syndrome (AIDS) is an infectious contagious disease produced by the human immunodeficiency virus (HIV) that causes progressive immunosuppression, making individuals susceptible to infections and opportunistic diseases. Despite its benefits, antiretroviral therapy has side effects, such as insulin resistance, dyslipidemia, high blood pressure and increased risk of cardiovascular disease. Objective: The aim of this study was to identify metabolic alterations in elderly patients with AIDS who use antiretroviral therapy (ART). Methods: The study consisted of a retrospective bibliographic review, including indexed articles published over the last 10 years, written in Portuguese and English, which evaluated changes in nutritional status and metabolic changes in HIV-positive patients who used ART. Results: According to the Brazilian Ministry of Health, the number of people over 65 with HIV grew by 103% in the last decade. The HIV virus has a long incubation period before the onset of the first symptoms of the disease, which results in AIDS. Dyslipidemia affects approximately 70% of HIV-infected patients who use ART, and occurs due to an increase in serum cholesterol, triglycerides and/or a reduction in HDL-cholesterol. Conclusion: The WHO recommends that nutritional interventions form part of HIV/AIDS control and treatment programs since they improve treatment adherence and ART effectiveness. In this context, a healthy diet that is adequate for the needs of the individual contributes to increased levels of CD4 T lymphocytes and reduces the harm caused by opportunistic infections, while improving intestinal absorption, as well as decreasing muscle loss and lipodystrophy syndrome, whose symptoms can significantly reduce the survival rates of patients.Keywords: HIV; AIDS; ART; Lipodystrophy syndrome (LS); Dyslipidemia; Insulin resistance.

show abstract

Rosuvastatina e ciprofibrato no tratamento da dislipidemia em pacientes com HIV

Abstract: The results of this study show that ciprofibrate and rosuvastatin or a combination of both can be considered an effective, safe and well-tolerated lipid-lowering treatment for patients with AIDS on highly active antiretroviral therapy.

Cited by 6 publications

References 27 publications

The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS

Comparativo farmacológico de tratamento de dislipidemias em crianças, diabéticos, HIV-positivos e idosos

Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced Dyslipidemia

Changes in the nutritional status of elderly patients with HIV diagnosis undergoing antiretroviral treatment

Contact Info

Product

Resources

About